{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:23:22Z","timestamp":1787009002755,"version":"build-2736575974"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,15]]},"DOI":"10.1093\/infdis\/jix162","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T00:55:29Z","timestamp":1490316929000},"page":"1590-1598","source":"Crossref","is-referenced-by-count":15,"title":["Discordant Effects of Licensed Meningococcal Serogroup B Vaccination on Invasive Disease and Nasal Colonization in a Humanized Mouse Model"],"prefix":"10.1093","volume":"215","author":[{"given":"Carolyn M.","family":"Buckwalter","sequence":"first","affiliation":[{"name":"Department of Molecular Genetics, University of Toronto, Ontario and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa G.","family":"Currie","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, University of Toronto, Ontario and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond S. W.","family":"Tsang","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Gray-Owen","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, University of Toronto, Ontario and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,3,27]]},"reference":[{"key":"key\n\t\t\t\t20180328171448_CIT0001","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11910-015-0524-6","article-title":"Invasive meningococcal disease in the 21st century\u2014an update for the clinician","volume":"15","author":"Dwilow","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"key":"key\n\t\t\t\t20180328171448_CIT0002","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1179\/2047773214Y.0000000126","article-title":"Global practices of meningococcal vaccine use and impact on invasive disease","volume":"108","author":"Ali","year":"2014","journal-title":"Pathog Glob Health"},{"key":"key\n\t\t\t\t20180328171448_CIT0003","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328171448_CIT0004","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/656741","article-title":"Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy","volume":"51","author":"Findlow","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328171448_CIT0005","volume-title":"JCVI position statement on use of Bexsero\u00ae meningococcal B vaccine in the UK","author":"Joint Committee on Vaccination and Immunisation","year":"2014"},{"key":"key\n\t\t\t\t20180328171448_CIT0006","first-page":"608","article-title":"Use of serogroup B meningococcal vaccines in persons aged \u226510 Years at increased risk for serogroup B meningococcal disease: recommendations of the Advisory Committee on Immunization Practices, 2015","volume":"64","author":"Folaranmi","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180328171448_CIT0007","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.15585\/mmwr.mm6441a3","article-title":"Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the Advisory Committee on Immunization Practices, 2015","volume":"64","author":"MacNeil","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180328171448_CIT0008","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1473-3099(13)70341-4","article-title":"A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328171448_CIT0009","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","article-title":"Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity","volume":"17","author":"Campbell","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20180328171448_CIT0010","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/cid\/ciu601","article-title":"A decade of herd protection after introduction of meningococcal serogroup C conjugate vaccination","volume":"59","author":"Bijlsma","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328171448_CIT0011","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/cid\/cis892","article-title":"Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity","volume":"56","author":"Kristiansen","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328171448_CIT0012","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1080\/21645515.2015.1108502","article-title":"Impact of vaccination on meningococcal epidemiology","volume":"12","author":"Stefanelli","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t20180328171448_CIT0013","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0140-6736(14)60842-4","article-title":"Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial","volume":"384","author":"Read","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328171448_CIT0014","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0882-4010(92)90004-8","article-title":"Intranasal infection of infant mice with Neisseria meningitidis","volume":"12","author":"Mackinnon","year":"1992","journal-title":"Microb Pathog"},{"key":"key\n\t\t\t\t20180328171448_CIT0015","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1139\/m84-159","article-title":"Experimental meningococcal infection in neonatal animals: models for mucosal invasiveness","volume":"30","author":"Salit","year":"1984","journal-title":"Can J Microbiol"},{"key":"key\n\t\t\t\t20180328171448_CIT0016","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/IAI.71.4.1849-1855.2003","article-title":"Development and evaluation of an improved mouse model of meningococcal colonization","volume":"71","author":"Yi","year":"2003","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180328171448_CIT0017","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1128\/IAI.00781-07","article-title":"Transgenic mice expressing human transferrin as a model for meningococcal infection","volume":"75","author":"Zarantonelli","year":"2007","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180328171448_CIT0018","doi-asserted-by":"crossref","first-page":"e1003509","DOI":"10.1371\/journal.ppat.1003509","article-title":"In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa","volume":"9","author":"Johswich","year":"2013","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20180328171448_CIT0019","doi-asserted-by":"crossref","first-page":"e10067","DOI":"10.1371\/journal.pone.0010067","article-title":"Generation of human CEACAM1 transgenic mice and binding of Neisseria Opa protein to their neutrophils","volume":"5","author":"Gu","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328171448_CIT0020","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1093\/emboj\/16.12.3435","article-title":"CD66 carcinoembryonic antigens mediate interactions between Opa-expressing Neisseria gonorrhoeae and human polymorphonuclear phagocytes","volume":"16","author":"Gray-Owen","year":"1997","journal-title":"EMBO J"},{"key":"key\n\t\t\t\t20180328171448_CIT0021","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1046\/j.1365-2958.1996.01551.x","article-title":"Carcinoembryonic antigens (CD66) on epithelial cells and neutrophils are receptors for Opa proteins of pathogenic neisseriae","volume":"22","author":"Virji","year":"1996","journal-title":"Mol Microbiol"},{"key":"key\n\t\t\t\t20180328171448_CIT0022","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1128\/IAI.05702-11","article-title":"Defining the roles of human carcinoembryonic antigen-related cellular adhesion molecules during neutrophil responses to Neisseria gonorrhoeae","volume":"80","author":"Sarantis","year":"2012","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180328171448_CIT0023","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2180-10-117","article-title":"CEACAM1 recognition by bacterial pathogens is species-specific","volume":"10","author":"Voges","year":"2010","journal-title":"BMC Microbiol"},{"key":"key\n\t\t\t\t20180328171448_CIT0024","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1086\/517385","article-title":"New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4","volume":"177","author":"Martin","year":"1998","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328171448_CIT0025","first-page":"125","article-title":"Results of an efficacy trial with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway","volume":"14","author":"Bjune","year":"1991","journal-title":"NIPH Ann"},{"key":"key\n\t\t\t\t20180328171448_CIT0026","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1086\/514821","article-title":"Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine","volume":"195","author":"Beernink","year":"2007","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328171448_CIT0027","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1086\/379375","article-title":"Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity","volume":"188","author":"Welsch","year":"2003","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328171448_CIT0028","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1086\/597806","article-title":"Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa","volume":"199","author":"Beernink","year":"2009","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328171448_CIT0029","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.vaccine.2013.03.063","article-title":"Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)","volume":"32","author":"Bettinger","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328171448_CIT0030","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1128\/IAI.00293-12","article-title":"Invasive potential of nonencapsulated disease isolates of Neisseria meningitidis","volume":"80","author":"Johswich","year":"2012","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180328171448_CIT0031","first-page":"241","article-title":"Animal models for meningococcal disease","volume":"66","author":"Gorringe","year":"2001","journal-title":"Methods Mol Med"},{"key":"key\n\t\t\t\t20180328171448_CIT0032","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1016\/j.vaccine.2010.05.014","article-title":"Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus","volume":"28","author":"Giuliani","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328171448_CIT0033","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.vaccine.2014.01.011","article-title":"Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero\u00ae vaccine","volume":"32","author":"Tani","year":"2014","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328171448_CIT0034","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/infdis\/jit239","article-title":"Importance of inhibition of binding of complement factor H for serum bactericidal antibody responses to meningococcal factor H-binding protein vaccines","volume":"208","author":"Konar","year":"2013","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328171448_CIT0035","doi-asserted-by":"crossref","first-page":"e01625","DOI":"10.1128\/mBio.01625-14","article-title":"Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding","volume":"5","author":"Costa","year":"2014","journal-title":"MBio"},{"key":"key\n\t\t\t\t20180328171448_CIT0036","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1371\/journal.pntd.0001302","article-title":"Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development","volume":"5","author":"Pajon","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20180328171448_CIT0037","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.vaccine.2015.12.034","article-title":"A meningococcal NOMV-FHbp vaccine for Africa elicits broader serum bactericidal antibody responses against serogroup B and non-B strains than a licensed serogroup B vaccine","volume":"34","author":"Pajon","year":"2016","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328171448_CIT0038","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3201\/eid2202.150369","article-title":"Effectiveness of meningococcal B vaccine against endemic hypervirulent Neisseria meningitidis W strain, England","volume":"22","author":"Ladhani","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20180328171448_CIT0039","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.vaccine.2015.01.057","article-title":"A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice","volume":"33","author":"Pajon","year":"2015","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328171448_CIT0040","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/IAI.01191-08","article-title":"Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera","volume":"77","author":"Granoff","year":"2009","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180328171448_CIT0041","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","article-title":"Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease","volume":"28","author":"Jiang","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328171448_CIT0042","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.vaccine.2010.12.075","article-title":"Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and neisserial heparin binding antigen","volume":"29","author":"Vu","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180328171448_CIT0043","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2958.2004.04423.x","article-title":"Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells","volume":"55","author":"Capecchi","year":"2005","journal-title":"Mol Microbiol"},{"key":"key\n\t\t\t\t20180328171448_CIT0044","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1128\/IAI.72.7.4217-4223.2004","article-title":"NadA diversity and carriage in Neisseria meningitidis","volume":"72","author":"Comanducci","year":"2004","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180328171448_CIT0045","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1128\/CVI.13.4.486-491.2006","article-title":"The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB","volume":"13","author":"Martin","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20180328171448_CIT0046","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328171448_CIT0047","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1073\/pnas.1521142113","article-title":"Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined","volume":"113","author":"Biagini","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180328171448_CIT0048","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/IAI.01085-12","article-title":"Transcriptional regulation of the nadA gene in Neisseria meningitidis impacts the prediction of coverage of a multicomponent meningococcal serogroup B vaccine","volume":"81","author":"Fagnocchi","year":"2013","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180328171448_CIT0049","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1128\/JCM.01322-10","article-title":"Persistence, replacement, and rapid clonal expansion of meningococcal carriage isolates in a 2008 university student cohort","volume":"49","author":"Bidmos","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180328171448_CIT0050","doi-asserted-by":"crossref","first-page":"e01974","DOI":"10.1128\/mBio.01974-14","article-title":"Emergence of a new epidemic Neisseria meningitidis serogroup a clone in the African meningitis belt: high-resolution picture of genomic changes that mediate immune evasion","volume":"5","author":"Lamelas","year":"2014","journal-title":"MBio"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/215\/10\/1590\/17667936\/jix162.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T02:17:44Z","timestamp":1522289864000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/215\/10\/1590\/3091147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,27]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,3,27]]},"published-print":{"date-parts":[[2017,5,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix162","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,5,15]]},"published":{"date-parts":[[2017,3,27]]}}}